Financials Yili Chuanning Biotechnology Co.,Ltd.

Equities

301301

CNE100005WX0

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-06-12 pm EDT 5-day change 1st Jan Change
13.52 CNY -0.59% Intraday chart for Yili Chuanning Biotechnology Co.,Ltd. +1.96% +60.95%

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 19,894 18,672 30,111 - -
Enterprise Value (EV) 1 19,894 18,672 30,111 30,111 30,111
P/E ratio 42.6 x 20 x 22.9 x 19.3 x 16.9 x
Yield - - - - -
Capitalization / Revenue - 3.87 x 5.33 x 4.77 x 4.36 x
EV / Revenue - 3.87 x 5.33 x 4.77 x 4.36 x
EV / EBITDA - 11.2 x 14.1 x 12.2 x 11 x
EV / FCF - - - - -
FCF Yield - - - - -
Price to Book - 2.68 x 3.68 x 3.15 x 2.72 x
Nbr of stocks (in thousands) 2,222,800 2,222,800 2,227,160 - -
Reference price 2 8.950 8.400 13.52 13.52 13.52
Announcement Date 3/12/23 4/10/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 - 4,823 5,650 6,307 6,914
EBITDA 1 - 1,666 2,143 2,467 2,738
EBIT 1 - 1,121 1,555 1,846 2,098
Operating Margin - 23.25% 27.52% 29.27% 30.34%
Earnings before Tax (EBT) 1 - 1,118 1,550 1,842 2,093
Net income 1 411.5 940.6 1,314 1,558 1,771
Net margin - 19.5% 23.26% 24.71% 25.62%
EPS 2 0.2100 0.4200 0.5900 0.7000 0.8000
Free Cash Flow - - - - -
FCF margin - - - - -
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 3/12/23 4/10/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt - - - - -
Net Cash position - - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow - - - - -
ROE (net income / shareholders' equity) - 14.3% 16.1% 16.4% 16.1%
ROA (Net income/ Total Assets) - 9.16% 12.3% 14.3% 14.2%
Assets 1 - 10,265 10,684 10,898 12,474
Book Value Per Share 2 - 3.130 3.680 4.290 4.970
Cash Flow per Share 2 - - 0.6300 0.7900 0.9100
Capex 1 - 345 590 488 436
Capex / Sales - 7.15% 10.45% 7.74% 6.31%
Announcement Date 3/12/23 4/10/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
13.52 CNY
Average target price
10.6 CNY
Spread / Average Target
-21.60%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 301301 Stock
  4. Financials Yili Chuanning Biotechnology Co.,Ltd.